COVID-19 vaccine: Govt will ensure people have access to vaccine as early as possible, says NITI Aayog member

By: |
Published: July 21, 2020 6:21 PM

COVID-19 vaccine: Dr Paul said that two Indian COVID-19 vaccines are in phase 1 and 2 of trials and discussions have begun as to how the vaccines will be made available to all those who require it.

India COVID-19 vaccine, COVID-19 vaccine, China SinoVac COVID-19 vaccine, India coronavirus vaccine, coronavirus vaccine, coronavirus, India COVID-19 vaccine Human clinical trials, ICMR, Dr Balram Bhargava, Drugs Controller General of India, DCGI, Bharat Biotech International Limited, Indian Council of Medical Research, Zydas Cadila Healthcare Ltd, human clinical trials, NITI Aayog, Dr VK Paul AIIMS Patna and PGI Rohtak have already begun conducting the clinical trials of the potential COVID-19 vaccine that is being jointly developed by the ICMR, National Institute of Virology, Pune, and Bharat Biotech. (Representational image)

COVID-19 vaccine: As all around the world the focus is now on a vaccine for Coronavirus, NITI Aayog member Dr VK Paul said on Tuesday that discussions are on as to how the COVID-19 vaccine will be made available to all those who need it.

ANI reported Dr Paul, Member (Health), NITI Aayog, as saying that two of India’s COVID-19 vaccines are in phase 1 and 2 of trials and discussions have begun as to how the vaccines will be made available to all those who require it.

The Government of India will ensure people of India and the international community have access to an Indian vaccine as early as possible, the NITI Aayog member avered, and added that all possible facilitation will be ensured to make sure the trials are conducted scientifically and ethically and that an affordable option is found.

As of now, the human trials of India’s indigenous COVAXIN are scheduled to take place at AIIMS-Delhi, Redkar Hospital in Goa, and Bhubaneswar’s Institute of Medical Sciences and SUM Hospital, among other places. AIIMS Patna and PGI Rohtak have already begun conducting the clinical trials of the potential COVID-19 vaccine that is being jointly developed by the Indian Council for Medical Research (ICMR), National Institute of Virology, Pune, and Bharat Biotech International Limited (BBIL).

Also on the list of probable centres where clinical trials of Covaxin will be conducted are medical institutes and hospitals located in Visakhapatnam, Belgaum in Karnataka, Nagpur, Uttar Pradesh’s Gorakhpur and Kanpur, Tamil Nadu’s Kattankulathur, Hyderabad, and Arya Nagar.

So far, the coronavirus vaccine candidate being developed by Oxford University and AstraZeneca has shown the most promising results as the scientists conducting the trial said on Monday that the vaccine can generate both antibodies and cell-mediated immune responses. The scientist community reacted to the potential breakthrough calling it very promising and interesting, while cautioning that there is still a long way to go.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 surge: Number of districts with over 1,000 cases double in a month
2Cornavirus cases: India overtakes US! Records highest single-day cases in the world
3Covid vaccine: Jubilant launches generic Remdesivir at Rs 4,700 per vial